
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Revenue | $4.7B | $4.6B | $5.3B | $5.6B | $6.1B | |
Revenue Growth (YoY) | -24.97% | -1.86% | 14.57% | 4.71% | 10.15% | |
Cost of Revenues | $2B | $1.9B | $1.9B | $2B | $2.2B | |
Gross Profit | $2.7B | $2.8B | $3.4B | $3.5B | $3.9B | |
Gross Profit Margin | 57.79% | 59.79% | 63.52% | 63.87% | 64.39% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $3.1B | $2.4B | $2.9B | $2.8B | $3.2B | |
Other Inc / (Exp) | -$613.2M | -$165.3M | $380.3M | $413.3M | -$143.4M | |
Operating Expenses | $3.4B | $2.6B | $3.1B | $3B | $3.4B | |
Operating Income | -$626.5M | $153.8M | $280.5M | $537.2M | $583.4M | |
Net Interest Expenses | $227.9M | $228.3M | $234M | $245.7M | $235.5M | |
EBT. Incl. Unusual Items | -$1.5B | -$239.8M | $426.8M | $704.8M | $204.5M | |
Earnings of Discontinued Ops. | $87.2M | -$137.3M | $5.7M | -- | -- | |
Income Tax Expense | -$377.7M | -$172M | $164.8M | $181.6M | $95.1M | |
Net Income to Company | -$1B | -$205.1M | $267.7M | $523.2M | $109.4M | |
Minority Interest in Earnings | -$4M | $3.8M | -$8.2M | -$15M | -$20M | |
Net Income to Common Excl Extra Items | -$1B | -$201.3M | $259.5M | $508.2M | $89.4M | |
Basic EPS (Cont. Ops) | -$1.33 | -$0.40 | $0.08 | $0.58 | $0.09 | |
Diluted EPS (Cont. Ops) | -$1.33 | -$0.40 | $0.08 | $0.57 | $0.09 | |
Weighted Average Basic Share | $759.1M | $764.8M | $820.6M | $849M | $874.4M | |
Weighted Average Diluted Share | $759.1M | $764.8M | $83.4B | $88.7B | $88.3B | |
EBITDA | -$517.8M | $577.3M | $1.2B | $1.4B | $877.2M | |
EBIT | -$1.2B | -$8M | $668M | $965.9M | $456.1M | |
Revenue (Reported) | $4.7B | $4.6B | $5.3B | $5.6B | $6.1B | |
Operating Income (Reported) | -$626.5M | $153.8M | $280.5M | $537.2M | $583.4M | |
Operating Income (Adjusted) | -$1.2B | -$8M | $668M | $965.9M | $456.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $1B | $1.2B | $1.3B | $1.4B | $1.3B | |
Revenue Growth (YoY) | -3.27% | 15.41% | 8.66% | 7.5% | -6.24% | |
Cost of Revenues | $391.7M | $423.1M | $478.1M | $487.8M | $466.7M | |
Gross Profit | $636.1M | $763.1M | $810.8M | $897.8M | $832.4M | |
Gross Profit Margin | 61.89% | 64.33% | 62.91% | 64.8% | 64.08% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $545.6M | $659.3M | $720.4M | $770.6M | $777.5M | |
Other Inc / (Exp) | $33.4M | $60.7M | $161.7M | -$19.5M | -$423.6M | |
Operating Expenses | $607.8M | $709.5M | $768.6M | $819.1M | $823.4M | |
Operating Income | $28.3M | $53.6M | $42.2M | $78.7M | $9M | |
Net Interest Expenses | $50.9M | $59.5M | $62.3M | $55.8M | $46M | |
EBT. Incl. Unusual Items | $10.8M | $54.8M | $141.6M | $3.4M | -$460.6M | |
Earnings of Discontinued Ops. | -$17.3M | $700K | -- | -- | -- | |
Income Tax Expense | -$19.2M | $500K | $29.8M | -$5.4M | -$58.4M | |
Net Income to Company | $12.7M | $55M | $111.8M | $8.8M | -$402.2M | |
Minority Interest in Earnings | $2.9M | -$1.4M | -$3.4M | -$5M | -$3.5M | |
Net Income to Common Excl Extra Items | $15.6M | $53.6M | $108.4M | $3.8M | -$405.7M | |
Basic EPS (Cont. Ops) | -$0.02 | $0.06 | $0.12 | -- | -$0.47 | |
Diluted EPS (Cont. Ops) | -$0.02 | $0.06 | $0.12 | -- | -$0.47 | |
Weighted Average Basic Share | $765.4M | $838.4M | $851.6M | $883.1M | $872.1M | |
Weighted Average Diluted Share | $765.4M | $852.9M | $865.2M | $892M | $872.1M | |
EBITDA | $208.9M | $237.6M | $314.2M | $166.6M | -$305.3M | |
EBIT | $62.5M | $115.7M | $206.8M | $62.2M | -$410.4M | |
Revenue (Reported) | $1B | $1.2B | $1.3B | $1.4B | $1.3B | |
Operating Income (Reported) | $28.3M | $53.6M | $42.2M | $78.7M | $9M | |
Operating Income (Adjusted) | $62.5M | $115.7M | $206.8M | $62.2M | -$410.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $4.1B | $5.2B | $5.4B | $6.1B | $6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.8B | $1.9B | $2B | $2.2B | $2.1B | |
Gross Profit | $2.4B | $3.3B | $3.4B | $3.9B | $3.9B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $2.4B | $2.7B | $2.9B | $3B | $3.2B | |
Other Inc / (Exp) | -$597.5M | $560.8M | $216M | -$38.5M | -$715.8M | |
Operating Expenses | $2.7B | $3B | $3.1B | $3.2B | $3.4B | |
Operating Income | -$310.2M | $320.8M | $355.8M | $674.9M | $553.5M | |
Net Interest Expenses | $225.9M | $242.5M | $226.6M | $245.7M | $216.4M | |
EBT. Incl. Unusual Items | -$1.1B | $639.1M | $345.2M | $390.7M | -$378.7M | |
Earnings of Discontinued Ops. | -$224.8M | $15.4M | $1.2M | -- | -- | |
Income Tax Expense | -$565.6M | $297.4M | $138.6M | $150.2M | -$2.2M | |
Net Income to Company | -$792.8M | $357.1M | $207.8M | $240.5M | -$376.5M | |
Minority Interest in Earnings | $11.2M | -$2.1M | -$14M | -$21.3M | -$19.5M | |
Net Income to Common Excl Extra Items | -$781.6M | $355M | $193.8M | $219.2M | -$396M | |
Basic EPS (Cont. Ops) | -$1.13 | $0.15 | $0.21 | $0.23 | -$0.47 | |
Diluted EPS (Cont. Ops) | -$1.15 | $0.15 | $0.20 | $0.23 | -$0.48 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$297.6M | $1.4B | $1B | $1.1B | $272.7M | |
EBIT | -$902.5M | $885M | $588.8M | $651.3M | -$147.1M | |
Revenue (Reported) | $4.1B | $5.2B | $5.4B | $6.1B | $6B | |
Operating Income (Reported) | -$310.2M | $320.8M | $355.8M | $674.9M | $553.5M | |
Operating Income (Adjusted) | -$902.5M | $885M | $588.8M | $651.3M | -$147.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.6B | $4.1B | $4.2B | $4.8B | $4.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.4B | $1.5B | $1.5B | $1.7B | $1.6B | |
Gross Profit | $2.1B | $2.6B | $2.7B | $3.1B | $3B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.8B | $2.2B | $2.1B | $2.4B | $2.4B | |
Other Inc / (Exp) | -$169.8M | $556.3M | $391.9M | -$59.9M | -$632.3M | |
Operating Expenses | $2B | $2.3B | $2.3B | $2.5B | $2.5B | |
Operating Income | $167M | $334M | $409.3M | $547M | $517.1M | |
Net Interest Expenses | $168.5M | $182.7M | $175.2M | $175.2M | $156.1M | |
EBT. Incl. Unusual Items | -$171.3M | $707.6M | $626M | $311.9M | -$271.3M | |
Earnings of Discontinued Ops. | -$148.2M | $4.5M | -- | -- | -- | |
Income Tax Expense | -$304.9M | $164.5M | $138.3M | $106.9M | $9.6M | |
Net Income to Company | -$14.6M | $547.6M | $487.7M | $205M | -$280.9M | |
Minority Interest in Earnings | -$700K | -$6.6M | -$12.4M | -$18.7M | -$18.2M | |
Net Income to Common Excl Extra Items | -$15.3M | $541M | $475.3M | $186.3M | -$299.1M | |
Basic EPS (Cont. Ops) | -$0.12 | $0.42 | $0.55 | $0.20 | -$0.36 | |
Diluted EPS (Cont. Ops) | -$0.14 | $0.42 | $0.54 | $0.20 | -$0.36 | |
Weighted Average Basic Share | $2.3B | $2.4B | $2.5B | $2.6B | $2.6B | |
Weighted Average Diluted Share | $2.4B | $2.5B | $2.6B | $2.7B | $2.6B | |
EBITDA | $436.1M | $1.3B | $1.1B | $815.8M | $211.3M | |
EBIT | -- | $893M | $813.8M | $499.2M | -$104M | |
Revenue (Reported) | $3.6B | $4.1B | $4.2B | $4.8B | $4.6B | |
Operating Income (Reported) | $167M | $334M | $409.3M | $547M | $517.1M | |
Operating Income (Adjusted) | -- | $893M | $813.8M | $499.2M | -$104M |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $308.3M | $253.5M | $233.3M | $246.9M | $300.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $440.1M | $348M | $364.6M | $360.9M | $441.6M | |
Inventory | $678.2M | $650.8M | $661.5M | $853.4M | $764.1M | |
Prepaid Expenses | $106.7M | $91.7M | $77.2M | $106.2M | $113.2M | |
Other Current Assets | $34M | $39.7M | $46M | $55.4M | $32.7M | |
Total Current Assets | $6.5B | $1.8B | $1.7B | $2.1B | $2B | |
Property Plant And Equipment | $1.5B | $1.2B | $1B | $999.6M | $974.2M | |
Long-Term Investments | -- | $1.3B | $842.6M | $1.1B | $1.1B | |
Goodwill | $4B | $4.1B | $3.9B | $4B | $3.9B | |
Other Intangibles | $4.4B | $4.5B | $3.9B | $3.8B | $3.6B | |
Other Long-Term Assets | $72.4M | $55.9M | $85.9M | $165.6M | $92.1M | |
Total Assets | $16.7B | $13.7B | $12.1B | $12.7B | $12.1B | |
Accounts Payable | $1.2B | $1.2B | $1.3B | $1.4B | $1.4B | |
Accrued Expenses | $639.6M | $693.4M | $701.7M | $681M | $679M | |
Current Portion Of Long-Term Debt | $188.3M | $50M | $23M | $57.9M | $3M | |
Current Portion Of Capital Lease Obligations | $105M | $75.7M | $67.8M | $65.6M | $57.8M | |
Other Current Liabilities | $1.1B | $104.7M | $131.5M | $69.7M | $76.1M | |
Total Current Liabilities | $3.6B | $2.4B | $2.6B | $2.7B | $2.6B | |
Long-Term Debt | $7.9B | $5.4B | $4.4B | $4.2B | $3.8B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $12.7B | $9.5B | $8.6B | $8.4B | $7.8B | |
Common Stock | $724.1M | $1B | $151.4M | $151.5M | $152M | |
Other Common Equity Adj | -$456.2M | -$321.9M | -$717.9M | -$662.4M | -$795.1M | |
Common Equity | $3B | $2.9B | $3.2B | $3.8B | $3.8B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $303.3M | $285.6M | $261.1M | $279.8M | $278.2M | |
Total Equity | $4B | $4.2B | $3.6B | $4.2B | $4.2B | |
Total Liabilities and Equity | $16.7B | $13.7B | $12.1B | $12.7B | $12.1B | |
Cash and Short Terms | $308.3M | $253.5M | $233.3M | $246.9M | $300.8M | |
Total Debt | $8.1B | $5.5B | $4.4B | $4.2B | $3.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $315.3M | $668.6M | $245M | $260.2M | $243.5M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $398.1M | $479.2M | $400.8M | $479.9M | $572.9M | |
Inventory | $604.7M | $643.1M | $798.1M | $759.7M | $717.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $457.4M | $381.7M | $438.6M | $459.8M | $380.5M | |
Total Current Assets | $1.8B | $2.2B | $1.9B | $2B | $1.9B | |
Property Plant And Equipment | $1.3B | $1.1B | $986.8M | $973.9M | $936.8M | |
Long-Term Investments | $1.3B | $1B | $1B | $1.1B | $1B | |
Goodwill | $4B | $4B | $4B | $4B | $3.9B | |
Other Intangibles | $4.5B | $4.1B | $3.9B | $3.6B | $3.1B | |
Other Long-Term Assets | $59.6M | $60.5M | $288.7M | $97.6M | $105.3M | |
Total Assets | $13.6B | $13.3B | $12.7B | $12.3B | $11.5B | |
Accounts Payable | $1.1B | $1.3B | $1.4B | $1.3B | $1.3B | |
Accrued Expenses | $1.2B | $1.2B | $1.1B | $1.1B | $962.7M | |
Current Portion Of Long-Term Debt | $193.7M | $516.5M | $68.3M | $4.4M | $9.4M | |
Current Portion Of Capital Lease Obligations | $79.3M | $68.5M | $61.1M | $58.8M | $58.6M | |
Other Current Liabilities | -- | -- | -- | -- | $1.1B | |
Total Current Liabilities | $2.6B | $3.2B | $2.8B | $2.5B | $2.4B | |
Long-Term Debt | $5.2B | $4.3B | $4.2B | $3.9B | $3.8B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $9.3B | $9.3B | $8.6B | $7.9B | $7.6B | |
Common Stock | $1B | $151.4M | $151.5M | $152M | $152M | |
Other Common Equity Adj | -$426M | -$520.3M | -$689.8M | -$712.6M | -$840.8M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $295.7M | $266.1M | $256.5M | $283.4M | $282.1M | |
Total Equity | $4.3B | $4B | $4.1B | $4.4B | $3.9B | |
Total Liabilities and Equity | $13.6B | $13.3B | $12.7B | $12.3B | $11.5B | |
Cash and Short Terms | $315.3M | $668.6M | $245M | $260.2M | $243.5M | |
Total Debt | $5.4B | $4.8B | $4.3B | $3.9B | $3.8B |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$1B | -$205.1M | $267.7M | $523.2M | $109.4M | |
Depreciation & Amoritzation | $716.5M | $585.3M | $516.4M | $426.7M | $421.1M | |
Stock-Based Compensation | $29.8M | $29.9M | $195.5M | $135.9M | $88.8M | |
Change in Accounts Receivable | $424.5M | $10.5M | -$77.2M | $36.8M | -$104.5M | |
Change in Inventories | $124.4M | $81.2M | -$48.3M | -$180.3M | $67.2M | |
Cash From Operations | -$50.9M | $318.7M | $726.6M | $625.7M | $614.6M | |
Capital Expenditures | $267.4M | $173.9M | $174.1M | $222.8M | $245.2M | |
Cash Acquisitions | $25.6M | $2.6B | $230.6M | -- | -- | |
Cash From Investing | -$833.4M | $2.4B | $269.7M | -$118.2M | -$226.2M | |
Dividends Paid (Ex Special Dividend) | -$196.9M | -$25.7M | -$57.2M | -$13.7M | -$13.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $4.7B | $4.5B | $1.5B | $1.6B | $4.3B | |
Long-Term Debt Repaid | -$4.2B | -$7.5B | -$2.2B | -$1.8B | -$4.6B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$96.5M | -$17.4M | -$255.7M | -$188.3M | -$351.7M | |
Cash From Financing | $877.3M | -$2.8B | -$1B | -$469.3M | -$336.7M | |
Beginning Cash (CF) | $380.4M | $352M | $310.4M | $263.8M | $283.8M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$7M | -$34.5M | -$37.7M | $38.2M | $51.7M | |
Ending Cash (CF) | $352M | $310.4M | $263.8M | $283.8M | $320.6M | |
Levered Free Cash Flow | -$318.3M | $144.8M | $552.5M | $402.9M | $369.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $12.7M | $55M | $111.8M | $8.8M | -$402.2M | |
Depreciation & Amoritzation | $146.4M | $121.9M | $107.4M | $104.4M | $105.1M | |
Stock-Based Compensation | $6.6M | $28.5M | $33.6M | $20.5M | $12.2M | |
Change in Accounts Receivable | $121.3M | $27.3M | $35.2M | $7.7M | $31.1M | |
Change in Inventories | $400K | -$50.3M | -$68.6M | $1.6M | $8M | |
Cash From Operations | -$186.3M | $24.8M | -$124.6M | -$170M | -$122.5M | |
Capital Expenditures | $32.1M | $47M | $53.9M | $64.3M | $42.9M | |
Cash Acquisitions | -$212.1M | $210.7M | -- | $23.9M | -$3M | |
Cash From Investing | -$242M | $206.9M | -$52.5M | -$42.1M | $28.1M | |
Dividends Paid (Ex Special Dividend) | -- | -$3.4M | -$3.3M | -$3.3M | -$3.2M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $771M | $4.8M | $497.7M | $611.2M | $934.4M | |
Long-Term Debt Repaid | -$585.9M | -$43.9M | -$329.4M | -$357.1M | -$618.9M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $5.3M | -$52.7M | -$26M | -$229.6M | -$235.1M | |
Cash From Financing | $190.4M | -$95.2M | $139M | $21.8M | $77.2M | |
Beginning Cash (CF) | $605.3M | $562.5M | $312.3M | $483.5M | $268.6M | |
Foreign Exchange Rate Adjustment | -$9.4M | $1.2M | $2.8M | -$7M | $8M | |
Additions / Reductions | -$237.9M | $136.5M | -$38.1M | -$190.3M | -$17.2M | |
Ending Cash (CF) | $358M | $700.2M | $277M | $286.2M | $259.4M | |
Levered Free Cash Flow | -$218.4M | -$22.2M | -$178.5M | -$234.3M | -$165.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$792.8M | $357.1M | $207.8M | $240.5M | -$376.5M | |
Depreciation & Amoritzation | $604.9M | $538.7M | $444.7M | $425.5M | $419.8M | |
Stock-Based Compensation | $40.6M | $165.3M | $130.1M | $107.4M | $63.1M | |
Change in Accounts Receivable | $161.2M | -$93.6M | $73.7M | -$84.6M | -$128.6M | |
Change in Inventories | $141.4M | -$43.1M | -$162.1M | $27.1M | $30.6M | |
Cash From Operations | $31M | $791.8M | $487.9M | $543M | $585.9M | |
Capital Expenditures | $204.7M | $163.2M | $197.1M | $252.2M | $226.5M | |
Cash Acquisitions | $3.2B | $244.7M | -$14.1M | $23.9M | -$11.3M | |
Cash From Investing | $2.4B | $251.2M | -$109.4M | -$182M | -$144.8M | |
Dividends Paid (Ex Special Dividend) | -$1.5M | -$78M | -$13.8M | -$13.4M | -$13.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2.3B | $3.3B | $1.6B | $3.5B | $3.2B | |
Long-Term Debt Repaid | -$6.6B | -$3.7B | -$2.2B | -$3.8B | -$3.3B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$4.3M | -$193.8M | -$261.3M | -$336.9M | -$307.5M | |
Cash From Financing | -$3.4B | -$695.4M | -$788.9M | -$335.8M | -$456.7M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$952.4M | $347.6M | -$410.4M | $25.2M | -$15.6M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$173.7M | $628.6M | $290.8M | $290.8M | $359.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$14.6M | $547.6M | $487.7M | $205M | -$280.9M | |
Depreciation & Amoritzation | $436.1M | $389.5M | $317.8M | $316.6M | $315.3M | |
Stock-Based Compensation | $28.9M | $164.3M | $98.9M | $70.4M | $44.7M | |
Change in Accounts Receivable | -$57.3M | -$161.4M | -$10.5M | -$131.9M | -$156M | |
Change in Inventories | $114.2M | -$10.1M | -$123.9M | $83.5M | $46.9M | |
Cash From Operations | $286.4M | $759.5M | $520.8M | $438.1M | $409.4M | |
Capital Expenditures | $143.7M | $133M | $156M | $185.4M | $166.7M | |
Cash Acquisitions | $2.6B | $244.7M | -- | $23.9M | $12.6M | |
Cash From Investing | $2.5B | $281.4M | -$97.7M | -$161.5M | -$80.1M | |
Dividends Paid (Ex Special Dividend) | -$1.5M | -$53.8M | -$10.4M | -$10.1M | -$9.9M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2.1B | $949.1M | $1.1B | $3B | $2B | |
Long-Term Debt Repaid | -$5.1B | -$1.4B | -$1.3B | -$3.3B | -$2.1B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $9.2M | -$167.2M | -$172.8M | -$321.4M | -$277.2M | |
Cash From Financing | -$2.7B | -$642.7M | -$397.6M | -$264.1M | -$384.1M | |
Beginning Cash (CF) | $1.5B | $1.3B | $827.2M | $1.1B | $896.7M | |
Foreign Exchange Rate Adjustment | -$10.1M | -$8.4M | -$12.3M | -$10.1M | -$6.4M | |
Additions / Reductions | $16.1M | $398.2M | $25.5M | $12.5M | -$54.8M | |
Ending Cash (CF) | $1.5B | $1.7B | $840.4M | $1.1B | $835.5M | |
Levered Free Cash Flow | $142.7M | $626.5M | $364.8M | $252.7M | $242.7M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.